Phibro Animal Health Gross Profit 2012-2025 | PAHC

Phibro Animal Health gross profit from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Phibro Animal Health Annual Gross Profit
(Millions of US $)
2025 $400
2024 $313
2023 $298
2022 $285
2021 $271
2020 $257
2019 $265
2018 $267
2017 $248
2016 $239
2015 $233
2014 $204
2013 $179
2012 $164
2011 $147
Phibro Animal Health Quarterly Gross Profit
(Millions of US $)
2025-09-30 $120
2025-06-30 $110
2025-03-31 $105
2024-12-31 $102
2024-09-30 $83
2024-06-30 $87
2024-03-31 $80
2023-12-31 $79
2023-09-30 $68
2023-06-30 $77
2023-03-31 $76
2022-12-31 $77
2022-09-30 $69
2022-06-30 $78
2022-03-31 $72
2021-12-31 $71
2021-09-30 $65
2021-06-30 $70
2021-03-31 $69
2020-12-31 $68
2020-09-30 $64
2020-06-30 $61
2020-03-31 $70
2019-12-31 $69
2019-09-30 $58
2019-06-30 $65
2019-03-31 $65
2018-12-31 $69
2018-09-30 $66
2018-06-30 $68
2018-03-31 $69
2017-12-31 $67
2017-09-30 $63
2017-06-30 $63
2017-03-31 $61
2016-12-31 $63
2016-09-30 $61
2016-06-30 $60
2016-03-31 $59
2015-12-31 $61
2015-09-30 $59
2015-06-30 $58
2015-03-31 $59
2014-12-31 $56
2014-09-30 $60
2014-06-30 $51
2014-03-31 $53
2013-12-31 $51
2013-09-30 $50
2013-06-30
2013-03-31 $46
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.097B $1.296B
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.241B 21.80
EssilorLuxottica (ESLOY) France $138.190B 0.00
Stryker (SYK) United States $138.078B 26.49
Medtronic (MDT) Ireland $130.022B 18.01
Boston Scientific (BSX) United States $110.071B 24.34
Medline (MDLN) United States $59.498B 0.00
Lonza Group Ag (LZAGY) Switzerland $47.159B 0.00
ResMed (RMD) United States $38.392B 25.64
Agilent Technologies (A) United States $36.486B 23.12
GE HealthCare Technologies (GEHC) United States $36.105B 17.30
Koninklijke Philips (PHG) Netherlands $31.690B 18.81
Terumo (TRUMY) Japan $20.046B 22.65
Zimmer Biomet Holdings (ZBH) United States $18.114B 11.15
Insulet (PODD) United States $17.756B 55.11
Smith & Nephew SNATS (SNN) United Kingdom $15.032B 0.00
Baxter (BAX) United States $11.278B 9.10
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $8.091B 29.09
Demant (WILYY) Denmark $6.264B 0.00
Envista Holdings (NVST) United States $4.961B 25.14
Lantheus Holdings (LNTH) United States $4.454B 13.57
BillionToOne (BLLN) United States $4.208B 0.00
ICU Medical (ICUI) United States $3.782B 24.02
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.128B 14.76
Haemonetics (HAE) United States $2.763B 12.09
Neogen (NEOG) United States $2.334B 51.10
LeMaitre Vascular (LMAT) United States $1.996B 40.17
QuidelOrtho (QDEL) United States $1.984B 12.76
Perrigo (PRGO) Ireland $1.980B 4.96
AtriCure (ATRC) United States $1.882B 0.00
Curaleaf Holdings (CURLF) Canada $1.615B 0.00
Kestra Medical Technologies (KMTS) United States $1.593B 0.00
AdaptHealth (AHCO) United States $1.441B 20.86
Green Thumb Industries (GTBIF) United States $1.423B 62.36
Lumexa Imaging Holdings (LMRI) United States $1.325B 0.00
Capricor Therapeutics (CAPR) United States $1.126B 0.00
BioLife Solutions (BLFS) United States $1.091B 323.57
InMode (INMD) Israel $0.924B 10.15
Tilray Brands (TLRY) Canada $0.912B 0.00
Valneva SE (VALN) France $0.846B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.798B 0.00
Omeros (OMER) United States $0.792B 0.00
CeriBell (CBLL) United States $0.771B 0.00
VAREX IMAGING (VREX) United States $0.593B 14.15
Brainsway (BWAY) Israel $0.457B 77.83
Verano Holdings (VRNO) United States $0.447B 0.00
Cerus (CERS) United States $0.428B 0.00
Canopy Growth (CGC) Canada $0.402B 0.00
SNDL (SNDL) Canada $0.384B 0.00
Cresco Labs (CRLBF) United States $0.368B 0.00
Viemed Healthcare (VMD) United States $0.315B 25.12
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
Evolus (EOLS) United States $0.288B 0.00
Quanterix (QTRX) United States $0.286B 0.00
TriSalus Life Sciences (TLSI) United States $0.227B 0.00
Sanuwave Health (SNWV) United States $0.221B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
High Tide (HITI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.207B 18.54
Aurora Cannabis (ACB) Canada $0.202B 59.33
OraSure Technologies (OSUR) United States $0.202B 0.00
TerrAscend (TSNDF) Canada $0.200B 0.00
Organigram Global (OGI) Canada $0.188B 0.00
Accendra Health (ACH) United States $0.184B 1.85
Sanara MedTech (SMTI) United States $0.174B 0.00
Vireo Growth (VREOF) United States $0.166B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.152B 0.00
FitLife Brands (FTLF) United States $0.135B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.135B 0.00
Fonar (FONR) United States $0.116B 16.86
MacroGenics (MGNX) United States $0.108B 0.00
Jushi Holdings (JUSHF) United States $0.104B 0.00
Biote (BTMD) United States $0.101B 4.42
Exagen (XGN) United States $0.079B 0.00
ImmuCell (ICCC) United States $0.060B 25.50
Sharps Technology (STSS) United States $0.049B 0.00
Rockwell Medical (RMTI) United States $0.043B 0.00
Cytosorbents (CTSO) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 29.92
Veru (VERU) United States $0.037B 0.00
Modular Medical (MODD) United States $0.033B 0.00
United-Guardian (UG) United States $0.031B 15.56
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.014B 0.00
INLIF (INLF) China $0.010B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Agape ATP (ATPC) $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00